Strong Revenue Growth
Total company revenue was $2.9 billion, representing growth of 26% year over year. Pharmacy Solutions revenue grew 28% year over year, while provider services revenue grew 12%.
Increased EBITDA and Guidance
Total company adjusted EBITDA was $131 million, growing 28% year over year. The company increased its EBITDA guidance for 2025 by $25 million at both the low and high ends of the prior range.
Specialty and Infusion Business Performance
Revenue growth for the Specialty and Infusion business was 33% year over year, with total script volume growth of 20% in the quarter.
High Quality Metrics in Health Services
Patient satisfaction rates remained high across various services, including a 90% satisfaction rate in home health and 98% in rehab.
Positive Market Positioning
The company demonstrated strong performance in the home and community settings, with a focus on high-quality care and innovative growth.